Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Record History section shows minor updates: Revision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe Record History shows a new Revision: v3.3.1 added and Revision: v3.2.0 removed, reflecting a minor update to the study record versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedA site-wide funding outage notice has been removed from the page, and the rest of the study record remains visible.SummaryDifference0.7%

- Check43 days agoChange DetectedA new version entry dated 2024-11-27 appears in the record history, showing updated study and recruitment status for NCT05560399. This reflects ongoing updates to the trial's official status on ClinicalTrials.gov.SummaryDifference0.1%

- Check71 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference12%

- Check79 days agoChange DetectedUpdates the page version from v3.0.2 to v3.1.0, indicating a new release tag without changing core content.SummaryDifference0.3%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.